174 related articles for article (PubMed ID: 15531914)
1. Smad4 deficiency in cervical carcinoma cells.
Baldus SE; Schwarz E; Lohrey C; Zapatka M; Landsberg S; Hahn SA; Schmidt D; Dienes HP; Schmiegel WH; Schwarte-Waldhoff I
Oncogene; 2005 Jan; 24(5):810-9. PubMed ID: 15531914
[TBL] [Abstract][Full Text] [Related]
2. Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancer.
Maliekal TT; Antony ML; Nair A; Paulmurugan R; Karunagaran D
Oncogene; 2003 Jul; 22(31):4889-97. PubMed ID: 12894231
[TBL] [Abstract][Full Text] [Related]
3. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
Báez A; Cantor A; Fonseca S; Marcos-Martinez M; Mathews LA; Muro-Cacho CA; Muñoz-Antonia T
Clin Cancer Res; 2005 May; 11(9):3191-7. PubMed ID: 15867212
[TBL] [Abstract][Full Text] [Related]
4. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta.
Jazag A; Ijichi H; Kanai F; Imamura T; Guleng B; Ohta M; Imamura J; Tanaka Y; Tateishi K; Ikenoue T; Kawakami T; Arakawa Y; Miyagishi M; Taira K; Kawabe T; Omata M
Oncogene; 2005 Jan; 24(4):662-71. PubMed ID: 15592526
[TBL] [Abstract][Full Text] [Related]
5. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
[TBL] [Abstract][Full Text] [Related]
6. Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7.
Boulay JL; Mild G; Reuter J; Lagrange M; Terracciano L; Lowy A; Laffer U; Orth B; Metzger U; Stamm B; Martinoli S; Herrmann R; Rochlitz C
Genes Chromosomes Cancer; 2001 Jul; 31(3):240-7. PubMed ID: 11391794
[TBL] [Abstract][Full Text] [Related]
7. Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.
Papadimitrakopoulou VA; Oh Y; El-Naggar A; Izzo J; Clayman G; Mao L
Clin Cancer Res; 1998 Mar; 4(3):539-44. PubMed ID: 9533520
[TBL] [Abstract][Full Text] [Related]
8. Expression of Smad4 in the FaDu cell line partially restores TGF-beta growth inhibition but is not sufficient to regulate fibronectin expression or suppress tumorigenicity.
Hummer BT; Bartlett C; Henry E; Weissman BE
J Cell Physiol; 2003 Mar; 194(3):289-302. PubMed ID: 12548549
[TBL] [Abstract][Full Text] [Related]
9. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
Levy L; Hill CS
Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the tumor suppressor gene Smad4/DPC4 induces p21waf1 expression and growth inhibition in human carcinoma cells.
Hunt KK; Fleming JB; Abramian A; Zhang L; Evans DB; Chiao PJ
Cancer Res; 1998 Dec; 58(24):5656-61. PubMed ID: 9865717
[TBL] [Abstract][Full Text] [Related]
11. Substantial changes in gene expression of Wnt, MAPK and TNFalpha pathways induced by TGF-beta1 in cervical cancer cell lines.
Kloth JN; Fleuren GJ; Oosting J; de Menezes RX; Eilers PH; Kenter GG; Gorter A
Carcinogenesis; 2005 Sep; 26(9):1493-502. PubMed ID: 15878915
[TBL] [Abstract][Full Text] [Related]
12. Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene.
Bläker H; von Herbay A; Penzel R; Gross S; Otto HF
Oncogene; 2002 Jan; 21(1):158-64. PubMed ID: 11791187
[TBL] [Abstract][Full Text] [Related]
13. Transfer of chromosome 18 into human head and neck squamous carcinoma cells: evidence for tumor suppression by Smad4/DPC4.
Reiss M; Santoro V; de Jonge RR; Vellucci VF
Cell Growth Differ; 1997 Apr; 8(4):407-15. PubMed ID: 9101086
[TBL] [Abstract][Full Text] [Related]
14. Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas.
Reinacher-Schick A; Baldus SE; Romdhana B; Landsberg S; Zapatka M; Mönig SP; Hölscher AH; Dienes HP; Schmiegel W; Schwarte-Waldhoff I
J Pathol; 2004 Apr; 202(4):412-20. PubMed ID: 15095268
[TBL] [Abstract][Full Text] [Related]
15. SMAD4 as a prognostic marker in colorectal cancer.
Alazzouzi H; Alhopuro P; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Hemminki A; Schwartz S; Aaltonen LA; Arango D
Clin Cancer Res; 2005 Apr; 11(7):2606-11. PubMed ID: 15814640
[TBL] [Abstract][Full Text] [Related]
16. Assessment of TGF-beta1-mediated growth inhibition of HPV-16- and HPV-18-transfected foreskin keratinocytes during and following immortalization.
Nindl I; Steenbergen RD; Schurek JO; Meijer CJ; van der Valk P; Snijders PJ
Arch Dermatol Res; 2003 Dec; 295(7):297-304. PubMed ID: 14576954
[TBL] [Abstract][Full Text] [Related]
17. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
[TBL] [Abstract][Full Text] [Related]
18. Concomitant overexpression of cyclooxygenase-2 in HER-2-positive on Smad4-reduced human gastric carcinomas is associated with a poor patient outcome.
Okano H; Shinohara H; Miyamoto A; Takaori K; Tanigawa N
Clin Cancer Res; 2004 Oct; 10(20):6938-45. PubMed ID: 15501972
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of Smad4 in gastric carcinomas.
Powell SM; Harper JC; Hamilton SR; Robinson CR; Cummings OW
Cancer Res; 1997 Oct; 57(19):4221-4. PubMed ID: 9331080
[TBL] [Abstract][Full Text] [Related]
20. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q.
Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J
Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]